- Home
- ROIV vs ALV Comparison
ROIV vs ALV Comparison
Compare ROIV & ALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- ALV
- Stock Information
- Founded
- ROIV 2014
- ALV 1953
- Country
- ROIV United Kingdom
- ALV Sweden
- Employees
- ROIV N/A
- ALV N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- ALV Auto Parts:O.E.M.
- Sector
- ROIV Health Care
- ALV Consumer Discretionary
- Exchange
- ROIV Nasdaq
- ALV Nasdaq
- Market Cap
- ROIV 8.4B
- ALV 7.2B
- IPO Year
- ROIV N/A
- ALV 1997
- Fundamental
- Price
- ROIV $10.67
- ALV $101.56
- Analyst Decision
- ROIV Buy
- ALV Buy
- Analyst Count
- ROIV 4
- ALV 11
- Target Price
- ROIV $17.50
- ALV $113.09
- AVG Volume (30 Days)
- ROIV 5.9M
- ALV 694.2K
- Earning Date
- ROIV 05-29-2025
- ALV 04-16-2025
- Dividend Yield
- ROIV N/A
- ALV 2.76%
- EPS Growth
- ROIV N/A
- ALV 35.84
- EPS
- ROIV N/A
- ALV 8.68
- Revenue
- ROIV $122,585,000.00
- ALV $10,353,000,000.00
- Revenue This Year
- ROIV N/A
- ALV N/A
- Revenue Next Year
- ROIV N/A
- ALV $3.53
- P/E Ratio
- ROIV N/A
- ALV $11.70
- Revenue Growth
- ROIV 140.04
- ALV N/A
- 52 Week Low
- ROIV $8.73
- ALV $75.49
- 52 Week High
- ROIV $13.06
- ALV $129.38
- Technical
- Relative Strength Index (RSI)
- ROIV 47.82
- ALV 70.95
- Support Level
- ROIV $10.58
- ALV $93.20
- Resistance Level
- ROIV $11.77
- ALV $102.95
- Average True Range (ATR)
- ROIV 0.34
- ALV 1.72
- MACD
- ROIV -0.07
- ALV 1.14
- Stochastic Oscillator
- ROIV 7.56
- ALV 88.76
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About ALV Autoliv Inc.
Autoliv Inc is the world-wide leader in passive safety components and systems for the auto industry. Products include seat belts, frontal air bags, side-impact air bags, air bag inflators, and steering wheels. The Renault-Nissan-Mitsubishi alliance is the company's largest customer at 10% of 2023 revenue, with Stellantis accounting for 10% and Volkswagen 9%. At 34% of 2023 revenue, the Americas was Autoliv's largest geographic region, followed by Europe at 27%, China at 20%, and rest of world at 19%.